Search research articles
Contact Us
Filters
Showing results (201-210 of 267) with videos related to
Page
of 27
Sort By:
Life Science Alliance
|
December 14, 2020
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis
Elisa Redl, Raheleh Sheibani-Tezerji, Crhistian de Jesus Cardona, et al.
Molecular Cancer
|
May 4, 2025
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
Emine Atas, Kerstin Berchtold, Michaela Schlederer, et al.
Oncoimmunology
|
July 3, 2015
Myeloid <i>STAT3</i> promotes formation of colitis-associated colorectal cancer in mice
Paulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, et al.
International Journal of Cancer
|
July 11, 2018
Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma
Christina Sternberg, Wolfgang Gruber, Markus Eberl, et al.
The Journal of Clinical Investigation
|
December 5, 2017
STAT5BN642H is a driver mutation for T cell neoplasia
Ha Thi Thanh Pham, Barbara Maurer, Michaela Prchal-Murphy, et al.
Molecular Cancer
|
March 28, 2026
[<sup>18</sup>F]FDG PET/CT multiomics identifies Hedgehog-driven HPV-negative head and neck squamous cell carcinoma
Stefan Stoiber, Daniel Pölöske, Clemens P Spielvogel, et al.
BJU International
|
July 21, 2015
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study
Romain Mathieu, Tobias Klatte, Ilaria Lucca, et al.
Nature
|
December 28, 2020
RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy
Magdalena Paolino, Rubina Koglgruber, Shane J F Cronin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2017
YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis
Koji Taniguchi, Toshiro Moroishi, Petrus R de Jong, et al.
Blood
|
October 4, 2017
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 267) with videos related to
Sort By:
Page
of 27
Life Science Alliance
|
December 14, 2020
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis
Elisa Redl, Raheleh Sheibani-Tezerji, Crhistian de Jesus Cardona, et al.
Molecular Cancer
|
May 4, 2025
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
Emine Atas, Kerstin Berchtold, Michaela Schlederer, et al.
Oncoimmunology
|
July 3, 2015
Myeloid <i>STAT3</i> promotes formation of colitis-associated colorectal cancer in mice
Paulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, et al.
International Journal of Cancer
|
July 11, 2018
Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma
Christina Sternberg, Wolfgang Gruber, Markus Eberl, et al.
The Journal of Clinical Investigation
|
December 5, 2017
STAT5BN642H is a driver mutation for T cell neoplasia
Ha Thi Thanh Pham, Barbara Maurer, Michaela Prchal-Murphy, et al.
Molecular Cancer
|
March 28, 2026
[<sup>18</sup>F]FDG PET/CT multiomics identifies Hedgehog-driven HPV-negative head and neck squamous cell carcinoma
Stefan Stoiber, Daniel Pölöske, Clemens P Spielvogel, et al.
BJU International
|
July 21, 2015
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study
Romain Mathieu, Tobias Klatte, Ilaria Lucca, et al.
Nature
|
December 28, 2020
RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy
Magdalena Paolino, Rubina Koglgruber, Shane J F Cronin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2017
YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis
Koji Taniguchi, Toshiro Moroishi, Petrus R de Jong, et al.
Blood
|
October 4, 2017
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe, et al.
Page
of 27